Clinical Trials Sponsored by Ferring Pharmaceuticals

Total 20929 results

Ferring Pharmaceuticals

Completed

Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Prostate Cancer

Belgium, Italy, Sweden, Portugal, Denmark, Finland, Norway, Turkey
Ferring Pharmaceuticals

Terminated

Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, United Kingdom, Germany
Ferring Pharmaceuticals

Withdrawn

Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®

Growth Hormone Deficiency
Ferring Pharmaceuticals

Completed

A Long Term Safety Study of Degarelix in Patients With Prostate Cancer

Prostate Cancer

Spain, France, Belgium, Italy, Sweden, Portugal, Turkey
Ferring Pharmaceuticals

Completed

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Prostate Cancer

United States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
Ferring Pharmaceuticals

Completed

Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Day Before PicoPrep

Bowel Preparation

United States
Ferring Pharmaceuticals

Completed

Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices

Gastrointestinal Bleeding | Oesophageal Varices

Romania
Ferring Pharmaceuticals

Completed

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Prostate Cancer

Spain, France, United States, Greece, United Kingdom, Germany, Netherlands
Ferring Pharmaceuticals

Completed

A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation

Constipation

China
Ferring Pharmaceuticals

Terminated

Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction (SOFTNES)

Cesarean Section | Vaginal Delivery

Brazil
Ferring Pharmaceuticals

Completed

Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease (CD05)

Crohn's Disease

United States, Netherlands, Israel, Belgium, Germany
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Central Diabetes Insipidus

Japan
Ferring Pharmaceuticals

Completed

A Study of Zomacton in Children With Growth Hormone Deficiency

Growth Hormone Deficiency

Israel, Hungary, India, Ukraine, Poland, Romania, Russian Federation
Ferring Pharmaceuticals

Completed

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

Labor, Induced | Cervical Ripening

United States, Canada
Ferring Pharmaceuticals

Completed

Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour

Cervical Ripening | Labor Induction

United Kingdom
Ferring Pharmaceuticals

Terminated

A Study With Pentasa in Patients With Active Crohn's Disease (PEACE)

Crohn´s Disease

United Kingdom, United States, Germany, Belgium, Denmark, France, Sweden
Ferring Pharmaceuticals

Terminated

The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"

Crohn's Disease

Sweden
Ferring Pharmaceuticals

Completed

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486

Prostate Cancer

United States
Ferring Pharmaceuticals

Terminated

Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients

Prostate Cancer

United States
Ferring Pharmaceuticals

Completed

Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

Fertility
Ferring Pharmaceuticals

Completed

Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

Ulcerative Colitis

Sweden, Netherlands, Denmark, Belgium, Finland, Czech Republic, Germany, Norway
Ferring Pharmaceuticals

Completed

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease

Crohn's Disease

Czech Republic
Ferring Pharmaceuticals

Completed

Efficacy and Safety Study of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding

United States
Ferring Pharmaceuticals

Completed

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Prostate Cancer

United States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
Ferring Pharmaceuticals

Completed

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Ferring Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

Infertility

Germany, United Kingdom
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Effectiveness and Safety of Firmagon® (FAST)

Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (PREDICT)

Infertility

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Compliance and Efficacy in the Use of PICOPREP® (CLEAR)

Bowel Cleanliness

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Quality of Life With TESTIM® (LIFE)

Hypogonadism

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

User Surveillance in Ulcerative Colitis (CARE)

Ulcerative Colitis

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

Growth Hormone Deficiency

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Mesalazine (PENTASA®) in Ulcerative Colitis (MUKOSA)

Ulcerative Colitis

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis (MELT)

Nocturnal Enuresis

Germany
Ferring Pharmaceuticals
Xanodyne Pharmaceuticals

Completed

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Menorrhagia

United States
Ferring Pharmaceuticals
DeltaMed

Completed

Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population

Bowel Cleansing

China
UNICANCER
Ferring Pharmaceuticals

Active, not recruiting

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy (GETUG-AFU22)

Adenocarcinoma of Prostate

France
Hillmont GI
Ferring Pharmaceuticals

Completed

Effects and Tolerability With Clenpiq and Low Residue Diet

Colonoscopy Preparation

United States
Queen's University
Ferring Pharmaceuticals

Completed

Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Hyponatremia | Hemodynamics

Canada
Clinique Ovo
Ferring Pharmaceuticals

Completed

Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle

Subfertility

Canada
Clinique Ovo
Ferring Pharmaceuticals

Completed

Personalizing Window of Implantation During Frozen Embryo Transfer (AdhesioRT)

Fertility

Canada
Lund University
Ferring Pharmaceuticals

Completed

Hormone Evaluation in Artificial Reproductive Technology (HEART)

Female Infertility

Poland, Sweden
Nordsjaellands Hospital
Ferring Pharmaceuticals

Terminated

Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis

Inflammatory Bowel Diseases | Ulcerative Colitis

Denmark
CMX Research
Ferring Pharmaceuticals

Completed

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists (DELAY)

Prostate Cancer

Canada
Clinique Ovo
Ferring Pharmaceuticals

Recruiting

Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation (Ooxyd)

Fertility Preservation

Canada
Clinique Ovo
Ferring Pharmaceuticals

Active, not recruiting

Rescue Progesterone Supplementation During Frozen Embryo Transfer (P4R)

Fertility Issues | Frozen Embryo Transfer | Embryo Implantation

Canada
Natera, Inc.
Ferring Pharmaceuticals

Terminated

Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer (IPSO)

In Vitro Fertilization (IVF) | Preimplantation Genetic Diagnosis (PGD) | Preimplantation Gentic Screening (PGS)

United States
University of Calgary
Ferring Pharmaceuticals

Not yet recruiting

Efficacy and Safety of Budesonide MMX® vs. Budesonide CR for Induction of Remission in Microscopic Colitis

Microscopic Colitis
The Cleveland Clinic
Ferring Pharmaceuticals

Terminated

Comparison of Clenpiq vs Golytely Bowel Preparation

Bowel Preparation Solutions

United States

Clinical Trials Sponsored by Ferring Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations